期刊
CLINICAL & TRANSLATIONAL ONCOLOGY
卷 25, 期 9, 页码 2665-2678出版社
SPRINGER INT PUBL AG
DOI: 10.1007/s12094-023-03203-8
关键词
Advanced breast cancer; ABC; Guidelines; Endocrine therapy; Anti-HER2 therapy; IOT; ADC
类别
Advanced breast cancer poses challenges for patients and physicians due to the genomic changes that lead to treatment resistance. The primary goal is to enhance patients' quality of life and survival through appropriate subsequent therapies based on understanding the disease's natural progression. These guidelines provide a summary of the current evidence and available medical management options for advanced breast cancer.
Advanced breast cancer represents a challenge for patients and for physicians due its dynamic genomic changes yielding to a resistance to treatments. The main goal is to improve quality of live and survival of the patients through the most appropriate subsequent therapies based on the knowledge of the natural history of the disease. In these guidelines, we summarize current evidence and available therapies for the medical management of advanced breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据